Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H0ZQ
|
|||
| Former ID |
DIB011192
|
|||
| Drug Name |
Ad35.CS.01
|
|||
| Synonyms |
Malaria vaccine (Ad35.CS), NIAID; Malaria vaccine (adenovirus, circumsporozoite), NIAID; Malaria vaccine (adenovirus, circumsporozoite), National Institute of Allergy and Infectious Diseases
Click to Show/Hide
|
|||
| Indication | Malaria [ICD-11: 1F40-1F45; ICD-10: B50-B64, B54] | Phase 1/2 | [1] | |
| Company |
National Institute of Allergy and Infectious Diseases
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01397227) A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.